Liver Diseases  >>  MK 8876  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MK 8876 / Merck (MSD)
NCT01930058: Safety, Pharmacokinetics, and Pharmacodynamics of MK-8876 in Participants With Hepatitis C Infection (MK-8876-003)

Completed
1
9
NA
MK-8876
Merck Sharp & Dohme LLC
Hepatitis C
05/14
05/14

Download Options